US4235772A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Novel peptides having growth promoting activity
Assignee: Phadia AB
•
Filing: 1979-06-20
•
Granted: 1980-11-25
•
Expires: 1999-06-20
Abstract
Abstract Described are novel growth promoting peptides of the general formula: P-Cys-Q-Cys-R where P is hydrogen, or Phe-Asn-Val-Asp-Lys-Lys-; Q is selected from -Gln-, or -Ser-Tyr-Tyr-Gln-Ser-Asn-, or -Tyr-Thr-Ala-Glu-; and R is selected from -Thr, -Lys-Pro-Gln-Val-Thr, or -Asp-Glu-Leu; and of the corresponding reduced linear form of any of the foregoing, as well as the corresponding pharmaceutically acceptable acid addition salts of any of the foregoing. The corresponding intermediates or intermediary compounds with amino and/or carboxyl groups protected are also covered.
Inventors
- 👤 Ronny-Hugo L. Lundin
- 👤 Gertrud E. Westin-Sjodahl
- 👤 Karin H. L. Bergendal
- 👤 Linda M. Fryklund
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 14:55
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/65; C07K14/61; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/12; Y10S930/26
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
79 words
A growth promoting polypeptide having the general formula P-Cys-Q-Cys-R, and the corresponding linear form thereof, wherein P is hydrogen, or Phe-Asn-Val-Asp-Lys-Lys-; Q is selected from -Gin, or -Ser-Tyr-Tyr-Gln-Ser-Asn-, or -Tyr-Thr-Ala-Glu-; and R is selected from -Thr, or -Lys-Pro -Gln-Val-Thr-, or -Asp-Glu-Leu-; and the corresponding peptide in which its reactive groups are projected in any of Asp, Cys, Glu, Lys, Ser, Thr, Tyr, Which are included; as well as the corresponding pharmaceutically acceptable acid addition salts of each said peptide.
Claim 2
Dependent Claim
79 words
A growth promoting polypeptide having the general formula P-Cys-Q-Cys-R, and the corresponding linear form thereof, wherein P is hydrogen, or Phe-Asn-Val-Asp-Lys-Lys-; Q is selected from -Gin, or -Ser-Tyr-Tyr-Gln-Ser-Asn-, or -Tyr-Thr-Ala-Glu-; and R is selected from -Thr, or -Lys-Pro -Gln-Val-Thr-, or -Asp-Glu-Leu-; and the corresponding peptide in which its reactive groups are projected in any of Asp, Cys, Glu, Lys, Ser, Thr, Tyr, Which are included; as well as the corresponding pharmaceutically acceptable acid addition salts of each said peptide.
Claim 3
Dependent Claim
26 words
A polypeptide as claimed in claim 1, which is Boc-Phe-Asn-Val-Asp(OBzl)-Lys(ε-2Brz)-Lys (ε-2Brz)-Cys(Acm)-Gln-Cys(Acm)-Asp(OBzl)-glu(OBzl)-Leu; and the correspondiing linear form, as well as its corresponding pharmaceutically acceptable acid addition salts.
Claim 4
Dependent Claim
25 words
A polypeptide as claimed in claim 1, which is Boc-Cys(4MeOBzl)-Ser(Bzl)-Tyr(2BrZ)-Tyr(2BrZ)-Gln-Ser(Bzl)-Asn-Cys(4MeOBzl)-Thr(Bzl); and the corresponding linear form, as well as its corresponding pharmaceutically acceptable acid addition salts.
Claim 5
Dependent Claim
26 words
A polypeptide as claimed in claim 1, which is Cys(Acm)-Tyr-Thr-Ala-Glu-Cys (Acm)-Lys-Pro-Gln-Val-Thr; and the corresponding linear form, as well as its corresponding pharmaceutically acceptable acid addition salts.
Claim 6
Dependent Claim
25 words
A polypeptide as claimed in claim 1, which is Phe-Asn-Val-Asp-Lys-Cys(Acm)-Gln-Cys(Acm)-Asp-Glu-Leu; and the corresponding linear form, as well as its corresponding pharmaceutically acceptable acid addition salts.
Claim 7
Dependent Claim
25 words
A polypeptide as claimed in claim 1, which is Cys-Ser-Tyr-Tyr-Gln-Ser-Asn-Cys-Thr; and the corresponding linear form, as well as its corresponding pharmaceutically acceptable acid addition salts.
Claim 8
Dependent Claim
25 words
A polypeptide as claimed in claim 1, which is Cys-Tyr-Thr-Ala-Glu-Cys-Lys-Pro-Gln-Val-Thr; and the corresponding linear form, as well as its corresponding pharmaceutically acceptable acid addition salts.
Claim 9
Dependent Claim
25 words
A polypeptide as claimed in claim 1, which is Phe-Asn-Val-Asp-Lys-Lys-Cys-Gln-Cys-Asp-Glu-Leu; and the corresponding linear form, as well as its corresponding pharmaceutically acceptable acid addition salts.
Claim 10
Dependent Claim
51 words
A method of promoting the cell production in the in vitro cultivation of mammalian tissue cells in a tissue cell culture medium, which comprises the step of incorporating in the culture medium a cell growth promoting content of a member of the class of the polypeptides as claimed in claim 1.
References Cited (Backward Citations)
US4058512A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-11-25 | 1984-05-26 | 1984-11-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-11-25 | 1988-05-26 | 1988-11-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-11-25 | 1992-05-26 | 1992-11-25 | $7700.00 | Window Closed / Lapsed |